Research and publication ethics

  • HOME
  • EDITORIAL POLICY
  • Research and publication ethics
  • 1. For the policies on research and publication ethics that are not stated in these instructions, the Good Publication Practice Guidelines for Medical Journals or the Guidelines on Good Publication Practice, Council of Science Editors, International Committee of Medical Journal Editors, World Association of Medical Editors, or Korean Association of Medical Journal Editors can be applied.

    1) Clinical trial registration
    Any research that deals with a clinical trial should be registered with a primary national clinical trial registration site accredited by the WHO or the International Committee of Medical Journal Editors.

    2) Conflict of interest
    Authors are required to disclose commercial or similar relationships to products or companies mentioned in or related to the subject matter of the article being submitted. Sources of funding for the article should be acknowledged before the reference section under the title of "Conflict of Interest". Affiliations of authors should include corporate appointments relating to or in connection with products or companies mentioned in the article.

    3) Ethical consideration

    • ① Informed Consent ‐ Manuscripts reporting the results of experimental investigation on human subjects must include a statement that informed consent was obtained.
    • ② Declaration of Helsinki ‐ A statement is required that the described research adhered to the tenets of the Declaration of Helsinki.
    • ③ When doing research on animal subjects, efforts should be made to minimize the pain and discomfort of experimental animals according to the guidelines of the Association for Research in Vision and Ophthalmology (ARVO) Statement for Use of Animals in Ophthalmic and Vision Research, and that should be stated.
    • ④ Ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and, unless inappropriate, report the sex and/or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex and gender. If the study was done involving an exclusive population, for example in only one sex, authors should justify why, except in obvious cases, (e.g., prostate cancer)." Authors should define how they determined race or ethnicity and justify their relevance.

    4) Description of participants
    Ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and, unless inappropriate, report the sex or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex or gender. If the study was done involving an exclusive population, for example in only one sex, authors should justify why, except in obvious cases (e.g., prostate cancer). Authors should define how they determined race or ethnicity and justify their relevance.

    5) Publication ethics
    Studies should pursue the fundamental principles of honesty, truthfulness, and accuracy in all research activities, and reject dishonest acts such as fabrication, falsification, and plagiarism.

    6) Secondary publication
    It is possible to republish manuscripts if it satisfies the condition of secondary publication of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals.

  • 2. All manuscripts should be prepared in strict observance of the research and publication ethics guidelines (http://kamje.or.kr/publishing_ethics.html) recommended by the Korean Association of Medical Journal Editors.
    • 1) Fabrication, falsification, and plagiarism
      The theme, subjects, size of the study, selection of control group, and method of collecting samples should be in accordance with research ethics. Research misconduct includes fabrication, falsification, and plagiarism. Authors have to follow the rules about publication ethics.
    • 2) Ethical approval and consent form
      Ethical approval and consent form IRB/Ethics Committee - Human subjects/materials/medical records - If the study involved human subjects, human-derived materials or human medical records, please include one of the following statements in the Methods section: "Institutional Review Board (IRB)/Ethics Committee approval was obtained" OR "IRB/Ethics Committee ruled that approval was not required for this study." If an IRB approved the study, IRB approval number should be written in the manuscript.
    • 3) Process for managing research and publication misconduct
      When the journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author's idea or data, complaints against editors, and soon, the resolution process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). The discussion and decision on the suspected cases are carried out by the Editorial Board.
  • 3. Authorship

    The AOCL adheres to the Uniform Requirements set by the International Committee of Medical Journal Editors (http://www.icmje.org/) for authorship. Authorship credit should be based on 1) substantial contributions to conception and design of the work; or the acquisition, analysis, or interpretation of data for the work; and 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published; and 4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Authors should meet these four conditions. It is the responsibility of the corresponding author to confirm that each coauthor meets the requirements for authorship. The corresponding author is primarily responsible for all issues to the editor and audience. Any comment of the corresponding author is regarded as opinion of all coauthors.

  • 4. Person with special relationship (PSR)

    1) When minors (under age 19) or family members (spouse, offspring, collateral blood relatives within the fourth degree) (a.k.a. person with special relationship; PSR) participated in submitting manuscript, the roles of PSR must be clearly stated.

    2) A "Pre-release form for Co-authoring a Publication with Person with Special Relationship" must be submitted, if PSR are included in the authors.

Annals of
Optometry
and Contact Lens

Print ISSN: 2384-0919
Online ISSN: 2384-0927

  • 382 Aberrations Using Zernike Polynomials and Contact Lens
    355 Patient Evaluation for Orthothokeratology Lens
    309 Principles of Adaptive Optics and Clinical Applications
    290 Clinical Characteristics of Miller-Fisher Syndrome and Bickerstaff Brainstem Encephalitis
    285 Effects of 0.15% Sodium Hyaluronate on Tear Film and Ocular Surface Disorders after Vitrectomy Surgery

    +more

    +more

    • GoogleScholar
    • Similarity Check
    • Crossref Cited-by Linking
    • CrossMark
    • Funder Registry
    • ORCID


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
Korea University Anam Hospital, 73 Inchon-ro, Seongbuk-gu, Seoul 02841, Korea
Tel: +82-2-2271-6603    Fax: +82-2-2277-5194    E-mail: journal@annocl.org                

Copyright © 2021 by The Korean Optometry Society and The Korean Contact Lens Study Society.

Developed in M2PI

Close layer
prev next